ArticleJournal of experimental & clinical cancer research : CR2019

ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway.

Qi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.